Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Proc Natl Acad Sci U S A ; 96(11): 6261-6, 1999 May 25.
Article in English | MEDLINE | ID: mdl-10339575

ABSTRACT

Two important cytokines mediating inflammation are tumor necrosis factor alpha (TNFalpha) and IL-1beta, both of which require conversion to soluble forms by converting enzymes. The importance of TNFalpha-converting enzyme and IL-1beta-converting enzyme in the production of circulating TNFalpha and IL-1beta in response to systemic challenges has been demonstrated by the use of specific converting enzyme inhibitors. Many inflammatory responses, however, are not systemic but instead are localized. In these situations release and/or activation of cytokines may be different from that seen in response to a systemic stimulus, particularly because associations of various cell populations in these foci allows for the exposure of procytokines to the proteolytic enzymes produced by activated neutrophils, neutrophil elastase (NE), proteinase 3 (PR3), and cathepsin G (Cat G). To investigate the possibility of alternative processing of TNFalpha and/or IL-1beta by neutrophil-derived proteinases, immunoreactive TNFalpha and IL-1beta release from lipopolysaccharide-stimulated THP-1 cells was measured in the presence of activated human neutrophils. Under these conditions, TNFalpha and IL-1beta release was augmented 2- to 5-fold. In the presence of a specific inhibitor of NE and PR3, enhanced release of both cytokines was largely abolished; however, in the presence of a NE and Cat G selective inhibitor, secretory leucocyte proteinase inhibitor, reduction of the enhanced release was minimal. This finding suggested that the augmented release was attributable to PR3 but not NE nor Cat G. Use of purified enzymes confirmed this conclusion. These results indicate that there may be alternative pathways for the production of these two proinflammatory cytokines, particularly in the context of local inflammatory processes.


Subject(s)
Interleukin-1/biosynthesis , Monocytes/physiology , Neutrophils/physiology , Protease Inhibitors/pharmacology , Serine Endopeptidases/metabolism , Tumor Necrosis Factor-alpha/biosynthesis , Cathepsin G , Cathepsins/metabolism , Coculture Techniques , Humans , Interleukin-1/metabolism , Kinetics , Leukocyte Elastase/metabolism , Lipopolysaccharides/pharmacology , Monocytes/cytology , Myeloblastin , Neutrophils/cytology , Protein Processing, Post-Translational , Proteinase Inhibitory Proteins, Secretory , Proteins/pharmacology , Serine Proteinase Inhibitors/pharmacology , Tumor Cells, Cultured , Tumor Necrosis Factor-alpha/metabolism
2.
Biochem Pharmacol ; 54(2): 283-91, 1997 Jul 15.
Article in English | MEDLINE | ID: mdl-9271333

ABSTRACT

The determination of the relationship between ligand affinity and bioactivity is important for the understanding of receptor function in biological systems and for drug development. Several physiological and pathophysiological functions of bradykinin (BK) are mediated via the B2 receptor. In this study, we have examined the relationship between B2 receptor (soluble and membrane-bound) binding of BK peptidic antagonists, inhibition of calcium signalling at a cellular level, and in vitro inhibition of ileum contraction. Only human systems were employed in the experiments. Good correlations between the studied activities of BK antagonists were observed for a variety of different peptidic structures. The correlation coefficients (r) were in the range of 0.905 to 0.955. In addition, we analyzed the effect of the C-terminal Arg9 removal from BK and its analogs on B2 receptor binding. The ratios of binding constants (Ki(+Arg)/Ki(-Arg)) for the Arg9 containing compounds and the corresponding des-Arg9 analogs varied from about 10 to 250,000. These ratios strongly depend on the chemical structures of the compounds. The highest ratios were observed for two natural agonist pairs, BK/des-Arg9-BK and Lys0-BK/des-Arg9-Lys0-BK.


Subject(s)
Bradykinin/antagonists & inhibitors , Calcium/metabolism , Ileum/metabolism , Receptors, Bradykinin/metabolism , Dihydromorphine/pharmacology , Humans , Ileum/physiology , In Vitro Techniques , Signal Transduction
3.
Mol Immunol ; 32(7): 523-9, 1995 May.
Article in English | MEDLINE | ID: mdl-7783755

ABSTRACT

A new basic antigen with a molecular weight of 36.5 kDa and a pI of 8.65 was purified from short ragweed pollen using ammonium sulfate precipitation, Q-sepharose chromatography and S-sepharose chromatography. The purified protein, herein referred to as Ambrosia artemisiifolia basic antigen (AaBA), migrated as a single band in SDS-polyacrylamide gel electrophoresis and isoelectric focusing, and as a single peak on reverse phase HPLC. AaBA reacted with sera from humans allergic to ragweed pollen including pooled NIH serum. AaBA and two major acidic allergens, Amb a I (antigen E) and Amb a II (antigen K), displayed immunological cross-reactivity inasmuch as they competed significantly with each other in a competition ELISA. This suggests that at least some major epitopes in all three antigens are similar; however, other possibilities like adjacent location of different epitopes cannot be ruled out at this time. Molecular weight, amino acid composition and sequence data suggest that AaBA is very similar to Amb a II whereas it is significantly different from other basic antigens purified from ragweed pollen.


Subject(s)
Allergens/isolation & purification , Pollen/immunology , Allergens/chemistry , Allergens/genetics , Amino Acid Sequence , Antibodies , Antigens, Plant , Cross Reactions , Female , Humans , In Vitro Techniques , Isoelectric Point , Male , Molecular Sequence Data , Molecular Weight , Plant Proteins/chemistry , Plant Proteins/genetics , Plant Proteins/immunology , Plant Proteins/isolation & purification , Pollen/chemistry , Pollen/genetics , Rhinitis, Allergic, Seasonal/immunology , Sequence Homology, Amino Acid
SELECTION OF CITATIONS
SEARCH DETAIL
...